Moderna to launch trials of new booster vaccine that targets South African Covid variant

The Boston-based biotech has already shipped the raw materials to the US National Institutes of Health, which helped the firm study its first jab, to start human trials.

from Health News | Mail Online https://ift.tt/3pOkpYF

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home